Skip to main content
SpringerLink
Log in

“Do I Really Have to Have Another Colonoscopy or Another CT Scan?”: Appropriate Disease Monitoring of Newly Diagnosed and Established Inflammatory Bowel Disease

  • Chapter
Inflammatory Bowel Disease

  • 1356 Accesses

Abstract

One of the biggest challenges in the management of inflammatory bowel disease (IBD) is to determine the etiology of patients’ symptoms. There is no single test that is the gold standard for evaluation of patients. A combination of selected tests is most likely to yield an explanation and direct the most appropriate therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Ricanek P, Brackmann S, Perminow G, Lyckander LG, Sponheim J, Holme O, et al. Evaluation of disease activity in IBD at the time of diagnosis by the use of clinical, biochemical, and fecal markers. Scand J Gastroenterol. 2011;46(9):1081–91.

    Article  CAS  PubMed  Google Scholar 

  2. Vieira A, Fang CB, Rolim EG, Klug WA, Steinwurz F, Rossini LG, et al. Inflammatory bowel disease activity assessed by fecal calprotectin and lactoferrin: correlation with laboratory parameters, clinical, endoscopic and histological indexes. BMC Res Notes. 2009;2:221.

    Article  PubMed Central  PubMed  Google Scholar 

  3. Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, et al. Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy. Am J Gastroenterol. 2000;95(10):2831–7.

    Article  CAS  PubMed  Google Scholar 

  4. Bunn SK, Bisset WM, Main MJ, Gray ES, Olson S, Golden BE. Fecal calprotectin: validation as a noninvasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2001;33(1):14–22.

    Article  CAS  PubMed  Google Scholar 

  5. Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Farkkila M. Crohn’s disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn’s disease activity index and endoscopic findings. Inflamm Bowel Dis. 2008;14(1):40–6.

    Article  PubMed  Google Scholar 

  6. Meuwis MA, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Piver E, et al. Serum calprotectin as a biomarker for Crohn’s disease. J Crohns Colitis. 2013;7(12):e678–83.

    Article  PubMed  Google Scholar 

  7. Beigel F, Deml M, Schnitzler F, Breiteneicher S, Goke B, Ochsenkuhn T, et al. Rate and predictors of mucosal healing in patients with inflammatory bowel disease treated with anti-TNF-alpha antibodies. PLoS One. 2014;9(6):e99293.

    Article  PubMed Central  PubMed  Google Scholar 

  8. Kerner C, Carey K, Mills AM, Yang W, Synnestvedt MB, Hilton S, et al. Use of abdominopelvic computed tomography in emergency departments and rates of urgent diagnoses in Crohn’s disease. Clin Gastroenterol Hepatol. 2012;10(1):52–7.

    Article  PubMed Central  PubMed  Google Scholar 

  9. Newnham E, Hawkes E, Surender A, James SL, Gearry R, Gibson PR. Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: are we contributing to malignancy? Aliment Pharmacol Ther. 2007;26(7):1019–24.

    Article  CAS  PubMed  Google Scholar 

  10. Levi Z, Fraser A, Krongrad R, Hazazi R, Benjaminov O, Meyerovitch J, et al. Factors associated with radiation exposure in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2009;30(11–12):1128–36.

    Article  CAS  PubMed  Google Scholar 

  11. Spinelli A, Fiorino G, Bazzi P, Sacchi M, Bonifacio C, De Bastiani S, et al. Preoperative magnetic resonance enterography in predicting findings and optimizing surgical approach in Crohn’s disease. J Gastrointest Surg. 2014;18(1):83–90. discussion-1.

    Article  PubMed  Google Scholar 

  12. Horsthuis K, Bipat S, Bennink RJ, Stoker J. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology. 2008;247(1):64–79.

    Article  PubMed  Google Scholar 

  13. Bernstein CN, Boult IF, Greenberg HM, van der Putten W, Duffy G, Grahame GR. A prospective randomized comparison between small bowel enteroclysis and small bowel follow-through in Crohn’s disease. Gastroenterology. 1997;113(2):390–8.

    Article  CAS  PubMed  Google Scholar 

  14. Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn’s disease. Gastro-enterology. 2010;138(2):463–8. quiz e10–1.

    Article  Google Scholar 

  15. Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, et al. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology. 2011;141(4):1194–201.

    Article  CAS  PubMed  Google Scholar 

  16. Ferrante M, Vermeire S, Fidder H, Schnitzler F, Noman M, Van Assche G, et al. Long-term outcome after infliximab for refractory ulcerative colitis. J Crohns Colitis. 2008;2(3):219–25.

    Article  PubMed  Google Scholar 

  17. Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology. 2009;137(4):1250–60. quiz 520.

    Article  CAS  PubMed  Google Scholar 

  18. Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn’s disease. Inflamm Bowel Dis. 2009;15(9):1295–301.

    Article  PubMed  Google Scholar 

  19. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. New Eng J Med. 1987;317(26):1625–9.

    Article  CAS  PubMed  Google Scholar 

  20. Daperno M, D’Haens G, Van Assche G, Baert F, Bulois P, Maunoury V, et al. Development and validation of a new, simplified endoscopic activity score for Crohn’s disease: the SES-CD. Gastrointest Endosc. 2004;60(4):505–12.

    Article  PubMed  Google Scholar 

  21. Fireman Z, Mahajna E, Broide E, Shapiro M, Fich L, Sternberg A, et al. Diagnosing small bowel Crohn’s disease with wireless capsule endoscopy. Gut. 2003;52(3):390–2.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Lucendo AJ, Guagnozzi D. Small bowel video capsule endoscopy in Crohn’s disease: what have we learned in the last ten years? World J Gastrointest Endosc. 2011;3(2):23–9.

    Article  PubMed Central  PubMed  Google Scholar 

  23. Niv E, Fishman S, Kachman H, Arnon R, Dotan I. Sequential capsule endoscopy of the small bowel for follow-up of patients with known Crohn’s disease. J Crohns Colitis. 2014;8(12):1616–23.

    Article  PubMed  Google Scholar 

  24. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2008;149(9):627–37.

    Article  Google Scholar 

  25. Leighton JA, Shen B, Baron TH, Adler DG, Davila R, Egan JV, et al. ASGE guideline: endoscopy in the diagnosis and treatment of inflammatory bowel disease. Gastrointest Endosc. 2006;63(4):558–65.

    Article  PubMed  Google Scholar 

  26. Farraye FA, Odze RD, Eaden J, Itzkowitz SH, McCabe RP, Dassopoulos T, et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):738–45.

    Article  PubMed  Google Scholar 

  27. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut. 2001;48(4):526–35.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Bernstein CN, Blanchard JF, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer. 2001;91(4):854–62.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, 1 Convention Ave, 9 Penn Tower, Philadelphia, PA, 19104, USA

    Karen A. Chachu M.D., Ph.D. & Gary R. Lichtenstein M.D.

Authors
  1. Karen A. Chachu M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gary R. Lichtenstein M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gary R. Lichtenstein M.D. .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Daniel J. Stein

  2. Chief, Division Gastroenterology and Hepatology Digestive Disease Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA

    Reza Shaker

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Chachu, K.A., Lichtenstein, G.R. (2015). “Do I Really Have to Have Another Colonoscopy or Another CT Scan?”: Appropriate Disease Monitoring of Newly Diagnosed and Established Inflammatory Bowel Disease. In: Stein, D., Shaker, R. (eds) Inflammatory Bowel Disease. Springer, Cham. https://doi.org/10.1007/978-3-319-14072-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-14072-8_20

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-14071-1

  • Online ISBN: 978-3-319-14072-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation